Financings in Brief: Medical Device Technologies Inc.
This article was originally published in The Gray Sheet
Executive Summary
Medical Device Technologies Inc.: Files registration statement with SEC for an offering of 1.5 mil. shares of cumulative convertible preferred stock to be sold by the company and certain selling shareholders. The preferred stock will pay dividends semi-annually, MDT says. Proceeds are slated to support marketing of the company's first medical device, the personal alarm system. Funds also will be used "to complete the development of the company's second and third medical devices, the Cell Recovery System and the Intracranial Pressure Monitoring Device, to repay indebtedness, and for working capital purposes," the firm says...
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.